Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Big share dump just now
View:
Post by DJDawg on Jun 01, 2023 12:34pm

Big share dump just now

Fascinating/appalling to watch.

Someone just sold something like 40k shares for 0.23 or 0.235

Right after the best clinical update to date.

Some people clearly have no faith in the company. (I don't either but I'm staying to see if the science will win the day despite the management)
Comment by ScienceFirst on Jun 01, 2023 1:12pm
DJDAWG... You talked too fast.  Back to 0.25$. “The stock market is a device for transferring money from the impatient to the patient.” - Warren Buffett
Comment by ScienceFirst on Jun 01, 2023 1:14pm
  Best example of something that has nothing to do with management. It's not the first time that flash crashes happen.  For absolutely no reason related to the company. ________ ScienceFirst - (6/1/2023 1:12:06 PM) RE:Big share dump just now DJDAWG... You talked too fast.  Back to 0.25$. “The stock market is a device for transferring money from the ...more  
Comment by DJDawg on Jun 01, 2023 1:31pm
Hah. You are right. I typed too soon.
Comment by ScienceFirst on Jun 01, 2023 1:32pm
Yep!
Comment by ScienceFirst on Jun 01, 2023 1:43pm
And one bought at the perfect time one was dumping.   With the recent data, the recent AUA shooted interview of Dr. Kulkarni/Dr. Kamat and the following, one that chickens out @0.23$ is just one that is not fitted for success.   The Board has unanimously agreed that it is in the best interests of Theralase and its shareholders that Roger resume the roles of President and CEO ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250